Cynthia M. Butitta's most recent trade in UroGen Pharma Ltd was a trade of 2,000 ordinary shares done . Disclosure was reported to the exchange on Nov. 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| UroGen Pharma Ltd | Cynthia M. Butitta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 2,000 | 2,000 (0%) | 0% | - | ordinary shares | |
| UroGen Pharma Ltd | Cynthia M. Butitta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 2,000 | 6,000 | - | - | Restricted Stock Unit | |
| UroGen Pharma Ltd | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 10,000 | 10,000 | - | - | Stock Option (right ot buy) | |
| UroGen Pharma Ltd | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 8,000 | 8,000 | - | - | Restricted Stock Unit | |
| Century Therapeutics Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 24,150 | 24,150 | - | - | Stock Option (right to buy) | |
| UroGen Pharma Ltd | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2024 | 10,000 | 10,000 | - | - | Stock Option (right ot buy) | |
| Century Therapeutics Inc | Cynthia M. Butitta | Director | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | ||
| Olema Pharma Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Cynthia M. Butitta | Director | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | ||
| Olema Pharma Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Olema Pharma Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Cynthia M. Butitta | Director | 09 Jun 2022 | 19,872 | 19,872 | - | - | Stock Option (right to buy) | ||
| UroGen Pharma Ltd | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Cynthia M. Butitta | Director | 17 Jun 2021 | 19,872 | 19,872 | - | - | Option (right to buy) | ||
| Olema Pharma Inc | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 21,520 | 21,520 | - | - | Stock Option (right to buy) | |
| UroGen Pharma Ltd | Cynthia M. Butitta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |